Business Directory, Press Releases, Jobs, Products, Services, Articles
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | News on Your Site

Press Releases


Press Release

Share      Blog

Receive press releases from Gilad&Gilad: By Email PDF Version RSS Feeds:

Another Agmatine Patent for Gilad&Gilad

The US Patent and Trademark Office (USPTO) has granted Gilad&Gilad an additional patent for agmatine use in dietary supplements, nutraceuticals, and foods.

Henderson, NV, April 04, 2017 --( The new patent, number 9,585,852 (issued on 03/07/2017), a continuation of patent 8,916,612 titled "Agmatine Containing Dietary Supplements, Nutraceuticals, and Foods," is a very significant and important landmark achievement for Gilad&Gilad. It broadens the patented use of agmatine beyond just neuroprotection. It now grants the company a unique market position by providing exclusive rights to tell users that supplements, nutraceuticals and foods which contain the effective high amounts of agmatine, afford not just protection of nerve cells, but can also impart general cytoprotection, i.e., protect many other cell types.

Agmatine is a metabolite of the amino acid arginine. It is biosynthesized via decarboxylation of arginine and exerts a wide range of unique physiological functions, all implicated in its salutary effects on the nervous system.

“Maintenance of normal nerve cell activities critically relies on the support of a variety of other cell types (e.g., vascular, muscular, connective and immune cells). In other words, proper nervous system functions depend on the concerted interactions of many cell types,” said Gilad&Gilad's CEO, Dr. Gad M. Gilad. “Agmatine with its postulated molecular shotgun-like mechanism of action is so unique, because as a single dietary ingredient it provides broad cytoprotection by modulating, potentially synergistically, multiple molecular mechanisms which underlie the cell's own molecular stress response. Consequently, by exerting general cytoprotection, agmatine provides not only for vigorous nervous system functions, but also for vitality of other bodily tissues, and that without unwanted side effects.”

According to Dr. Gilad, “The company has made substantial investments in scientific and clinical studies as well as in developing its intellectual property, which in turn provide claim substantiations and protection for promoting our agmatine-containing products for nerve health.”

"As of now, there are no additional indications which are backed by clinical studies,” Dr. Gilad emphasized. “That agmatine is touted for bodybuilding, is completely unsubstantiated and is misleading as it is backed by outright false claims."

Gilad&Gilad LLC is a health science company with unique competency in Neuroscience. The company has developed the exclusive For-Nerve-Health(TM) line of products based on the breakthrough discovery of the neuroprotective properties agmatine. AgmaSet® and AgmaVet(TM) are first-of-their-kind nutraceuticals containing G-Agmatine® (Gilad&Gilad's proprietary brand of agmatine) with superior effectiveness for healthy nerve functions. For further information, visit: - For wholesale discounts and for business opportunities, please contact Gilad&Gilad directly.
Contact Information
Gad M. Gilad, PhD

Click here to view the list of recent Press Releases from Gilad&Gilad
Promote Your Business